Azerbaijan vs Chad: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Azerbaijan
52.0%
in 2025
Chad
49.0%
in 2025
Azerbaijan rank
155th
Chad rank
156th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Azerbaijan
- Chad
How they compare
Azerbaijan currently reports 52.0% against 49.0% in Chad, a difference of 3.0%.
That makes Azerbaijan's figure about 1.1 times Chad's.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Chad ahead.
Azerbaijan ranks 155th and Chad ranks 156th of 194 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 42.0% | 0.0% | 42.0% | Azerbaijan |
| 2020s | 50.8% | 8.2% | 42.7% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Azerbaijan or Chad?
- Azerbaijan, at 52.0% against 49.0% in Chad as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Azerbaijan and Chad?
- 3.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Chad?
- 18 years are reported by both, from 2008 to 2025.
- How do Azerbaijan and Chad rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Azerbaijan ranks 155th and Chad ranks 156th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.